In a race against time, Oxford researchers are fast-tracking a vaccine for the Bundibugyo Ebola strain currently spreading in northeastern Democratic Republic of Congo—using a proven viral-vector platform that could help contain the outbreak.

The team's approach builds on existing vaccine technology, meaning they can move swiftly rather than starting from scratch. By leveraging platforms already tested and refined through previous health crises, researchers aim to get protective vaccines to vulnerable populations as quickly as possible. Read the full story →

Today's takeaway: When scientific innovation meets urgent need, proven methods can be adapted rapidly to save lives—a powerful reminder that preparedness and research investment pay dividends when crisis strikes.